Licensing Activities Sample Clauses
The Licensing Activities clause defines the rights and responsibilities related to the use, development, and commercialization of licensed intellectual property. It typically outlines what activities the licensee is permitted to undertake, such as manufacturing, marketing, or sublicensing the licensed technology or product, and may specify any limitations or required approvals. This clause ensures both parties have a clear understanding of the scope of permitted activities, thereby reducing the risk of disputes and facilitating effective management of the licensed assets.
Licensing Activities. Report in this section the time spent by county personnel in nurseries for initial inspection of new applicants for a License to Sell Nursery Stock, or for verifying a License to Sell Nursery Stock. Indicate the number of nurseries licensed under the column ‘new’ or ‘renewals’ as appropriate, and the time spent on such activity in the last column (hours). Name(s) of nursery must be entered on the supplemental sheet for report number 7
Licensing Activities the efforts of RECIPIENT or its Collaborator to negotiate, execute or enforce a License Agreement.
Licensing Activities. The grantee institutions that developed the present technology have made a substantial effort to license this invention. The following U.S. companies that manufacture and market technologies in this field have had an opportunity to review this invention for the purpose of licensing: ▇▇▇▇▇▇ Laboratories, Avid Therapeutics, ▇▇▇▇▇▇▇-▇▇▇▇▇ Squibb, Gilead Sciences, Lipitek International, Microscobe Corporation, and OncoRx. Unfortunately, no U.S. companies have sufficient interest to license this invention. There are several competing technologies to this invention. The grantee institutions are not certain but they believe one of the reasons they have not been successful in securing a U.S. manufacturer is due to these competing technologies. Two of the other competing technologies are nucleoside analogs and the U.S. market for treatment of HBV is apparently too small for U.S. companies to pursue another alternative therapy. Further, it follows that if the U.S. market is not large enough to attract a domestic manufacturer, it would not be commercially feasible to create an FDA compliant facility to manufacture the subject compounds in the U.S.
Licensing Activities. The Company will license its Patent Rights on a royalty-free basis to any Person that enters into a Company Licensing Agreement. The Company CEO will, subject to the approval of the Company Board, be responsible for the negotiation and execution of each Company Licensing Agreement, provided that any license of the Company’s Patent Rights that is not substantially in the form of the Form Company Licensing Agreement (as the same may be amended or modified from time to time) shall (in accordance with Section 4.02(c)(i)) [**].
Licensing Activities. Notwithstanding anything in this Section 2 to the contrary, Executive shall be permitted to engage in any licensing activities permitted by the License Agreement.
Licensing Activities. With respect to any Net Payment paid by a Licensee to either party as a direct result of IPM's Licensing Activities hereunder, IPM will receive a commission of fifteen percent (15%) of each such Net Payment;
Licensing Activities. All actions completed by the licensing personnel related to the enforcement of local and state child care requirements, such as issuance of licenses, site visits related to issuance/re-issuance of licenses, denial of licenses, applications processed, enforcement actions, provider training activities, technical assistance, site inspections, investigation of complaints, public hearings, imposing of fines, publication and dissemination of licensing requirements, and school readiness inspections.
Licensing Activities. For sake of clarity, Alliacense licensing duties and responsibilities under the Alliacense Services Agreement include, but are not limited to the following:
1) Define and develop worldwide licensing strategies;
2) Study patent coverage for specific products;
3) Develop claim charts to support Licensing Activities, but not litigation activities, provided however that PDS shall be responsible for the cost of acquiring the products of prospective licensees for the purpose of analyzing such products to create claim charts, but only to the extent PDS has provided written authorization for such acquisitions;
4) Coordinate and manage licensing duties with outside legal counsel;
5) Coordinate with legal counsel licensing data needs in patent litigation;
6) Review and assess potential licensee candidates;
7) Evaluate marketability of patents;
8) Maintain and manage database of licensees relating to all MMP patent procedures and processes;
9) Assist PDS with compliance of local, state and federal reporting relating to patent issues;
10) Review patent issues in mergers and acquisitions; and
11) Perform other duties, as reasonably requested by Patent owner and agreed to by Alliacense. Notwithstanding the foregoing, Alliacense shall not be obligated to provide any litigation support services. However, if Alliacense is requested in writing by PDS within no less than ten days advance notice of relevant deadlines, but declines to provide such litigation support services, its total fee, if any, shall be calculated [*].
Licensing Activities. IPM may (i) contact and discuss with Existing Licensees the status of such Existing Licensees' compliance with the terms and conditions of such Existing Licensees' respective License Agreements, and renegotiate such License Agreements, subject to Censtor's written approval, which approval will not be unreasonably withheld; and (ii) identify potential New Licensees, and discuss and negotiate with each such New Licensee the terms and conditions of a License Agreement, subject to Censtor's written approval of such License Agreement, which approval will not be unreasonably withheld (collectively, "Licensing Activities").